Clinical Trial Update: 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab [Phase 3]

View source ↗

Summary

A phase 3 trial evaluating 5-FU based maintenance therapy after induction with FOLFOX plus panitumumab in RAS wild-type metastatic colorectal cancer; study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma
• Colorectal Cancer

Drugs mentioned

• 5-FU (5-fluorouracil)
• FOLFOX
• Panitumumab (panitumumab)

Snippet

Sponsor: University of Southern California | Conditions: Colorectal Adenocarcinoma, RAS Wild Type | Phase 3 | Status: TERMINATED